Genetic Engineering & Biotechnology News (GEN) is the most authoritative biotechnology publication in the world and serves as an indispensable resource for busy biotech professionals who want to keep current in the areas of biotech business trends, drug discovery, OMICS, bioprocessing, translational medicine and many more.
GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN’s unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
Since its launch in 1981, GEN’s print coverage includes industry-standard tutorials and technical articles in bioprocessing, assays, and drug discovery; feature articles on emerging technologies; product roundups and regional biofocus articles on biotech hotbeds; as well as reports from key scientific and industry meetings.
GEN acclaimed columns include Wall Street BioBeat, Point of View, Corporate Profile, Biomarket Trends, Legal Affairs, Best of the Web, and Best Science Apps. Other regular, informative content includes New Product listings and the Calendar of Events column for bioscience and bioindustry meetings. GEN’s print edition also features the following news columns: Clinical Trials, Genomics & Proteomics, Discovery and Development, Bioprocessing, Molecular Diagnostics, Inside Industry, Products & Services, and People in the News.
Genetic Engineering & Biotechnology News Magazine – Free Subscription
Geographic Eligibility: Selected International